ChemicalBook > CAS DataBase List > 1622848-92-3
1622848-92-3
Product Image
Identification
Name
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
CAS
1622848-92-3
Synonyms
GSK2982772
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
Molecular Formula
C20H19N5O3
Molecular Weight
377.4
MOL File
1622848-92-3.mol
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
CAS
1622848-92-3
Synonyms
GSK2982772
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
Molecular Formula
C20H19N5O3
Molecular Weight
377.4
MOL File
1622848-92-3.mol
Chemical Properties
density
1.40±0.1 g/cm3(Predicted)
storage temp.
-20°C
solubility
Soluble in DMSO (>25 mg/ml)
form
solid
pka
8.80±0.40(Predicted)
color
Off-white
Stability:
Stable for 2 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
1.40±0.1 g/cm3(Predicted)
storage temp.
-20°C
solubility
Soluble in DMSO (>25 mg/ml)
form
solid
pka
8.80±0.40(Predicted)
color
Off-white
Stability:
Stable for 2 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
Questions and Answers (Q&A)
Description
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide, also known as GSK2982772, is a first-in-class receptor interacting protein 1(RIP1)-kinase specific clinical candidate for the treatment of inflammatory disease. It is an inhibitor of RIP1 that regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases. It has excellent activity in blocking many TNF-dependent cellular responses. Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous production of cytokines from human ulcerative colitis explants.
References
Harris, P. A., et al. "Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases." Journal of Medicinal Chemistry 60.4(2017):1247-1261.
Jeong, Jae Uk, et al. "Synthesis of ( S )-3-amino-benzo[ b ][1,4]oxazepin-4-one via Mitsunobu and S N Ar reaction for a first-in-class RIP1 kinase inhibitor GSK2982772 in clinical trials." Tetrahedron Letters 58.23(2017):2306-2308.
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide, also known as GSK2982772, is a first-in-class receptor interacting protein 1(RIP1)-kinase specific clinical candidate for the treatment of inflammatory disease. It is an inhibitor of RIP1 that regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases. It has excellent activity in blocking many TNF-dependent cellular responses. Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous production of cytokines from human ulcerative colitis explants.
References
Harris, P. A., et al. "Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases." Journal of Medicinal Chemistry 60.4(2017):1247-1261.
Jeong, Jae Uk, et al. "Synthesis of ( S )-3-amino-benzo[ b ][1,4]oxazepin-4-one via Mitsunobu and S N Ar reaction for a first-in-class RIP1 kinase inhibitor GSK2982772 in clinical trials." Tetrahedron Letters 58.23(2017):2306-2308.
SupplierMore
- Dezhou LonWel Pharmaceutical Technology Co., Ltd.
- Telephone 13761310616
- Websitehttps://www.chemicalbook.com/ShowSupplierProductsList20080/0.htm
- Shanghai Boyle Chemical Co., Ltd.
- Telephone
- Websitehttp://www.boylechem.com
- TargetMol Chemicals Inc.
- Telephone021-021-33632979 15002134094
- Websitehttps://www.targetmol.cn/
- ShangHai Caerulum Pharma Discovery Co., Ltd.
- Telephone021-64556180 15000803246
- Websitehttp://www.caerulumpharma.com
- Shanghai YuanQi Biotechnology Co., Ltd.
- Telephone 18120098618
- Websitehttps://www.chemicalbook.com/ShowSupplierProductsList16784/0.htm
- Shanghai Lollane Biological Technology Co.,Ltd.
- Telephone021-52996696 15000506266
- Websitehttp://www.bioll.com
- Shanghaizehan biopharma technology co., Ltd.
- Telephone021-61350663 13052117465
- Websitehttp://www.zehanbiopharma.com
- DebyeTec.com Inc.
- Telephone 18086626237
- Websitehttps://www.chemicalbook.com/ShowSupplierProductsList16955/0.htm
- ShangHai Angti Biotechnology Co., Ltd.
- Telephone 13764913901
- Websitehttp://www.angtibio.com
- Chengdu DingDang Pharmaceutical Co., Ltd.
- Telephone028-86040038
- Websitehttp://www.dingdangchem.com
- skychemical Co.Ltd
- Telephone021-20917629
- Websitehttp://www.skychemical.com
- Shanghai EFE Biological Technology Co., Ltd.
- Telephone021-65675885
- Websitehttp://www.efebio.com
- Shanghai Changyan Chem & Tech Co., Ltd.
- Telephone021-20242659
- Websitehttp://www.changyanchem.com
- ShangHai Biochempartner Co.,Ltd
- Telephone17754423994 17754423994
- Websitehttps://www.biochempartner.com
- Shanghai Rechem science Co., Ltd.
- Telephone21-51623867 15618786686
- Websitehttp://cn.rechemscience.com
- Shanghai Chaolan Chemical Technology Center
- TelephoneQQ：65489617 15618227136
- Website
- Shanghai SuperLan Chemcial Technique Centre
- TelephoneQQ：2022843681 15618226720
- Website
- Amadis Chemical Company Limited
- Telephone571-89925085
- Websitehttp://www.amadischem.com